Cloning the complete guinea pig cytomegalovirus genome as an infectious bacterial artificial chromosome with excisable origin of replication

Journal of Virological Methods

Volumn 149, Issue 2, 2008, Pages 231-239

  Cui, Xiaohong ^a   McGregor, Alistair ^b   Schleiss, Mark R ^b   McVoy, Michael A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

BAC; Congenital infection; Cytomegalovirus; GPCMV

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; LIVE VACCINE; RESTRICTION ENDONUCLEASE;

ANIMAL CELL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE TRANSMISSION; ESCHERICHIA COLI; FETUS DISEASE; GENE DELETION; GENOME; GUINEA PIG; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; VIROGENESIS; VIRUS REPLICATION;

ANIMALS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CLONING, ORGANISM; ESCHERICHIA COLI; GENOME, VIRAL; GUINEA PIGS; INTEGRASES; PLAQUE ASSAY; REPLICATION ORIGIN; RESTRICTION MAPPING; ROSEOLOVIRUS; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); CYTOMEGALOVIRUS; ESCHERICHIA COLI; GUINEA PIG CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 41349100866     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2008.01.031     Document Type: Article

References (30)

1. Borst E.M., Hahn G., Koszinowski U.H., and Messerle M. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. J. Virol. 73 10 (1999) 8320-8329
2. Bravo F.J., Cardin R.D., and Bernstein D.I. Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection. J. Infect. Dis. 193 4 (2006) 591-597
3. Chang W.L., and Barry P.A. Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis. J. Virol. 77 9 (2003) 5073-5083
4. Chatterjee A., Harrison C.J., Britt W.J., and Bewtra C. Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein b antibody transfer in guinea pigs. J. Infect. Dis. 183 11 (2001) 1547-1553
5. Chee M.S., Bankier A.T., Beck S., Sohni R., Brown C.M., Cerny R., Horsnell T., Hutchinson C.A., Kouzarides T., Marignetti J.A., Preddie E., Satchwell S.C., Tomlinson P., Weston K., and Barrell B.G. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. In: McDougall J.K. (Ed). Cytomegaloviruses. Current Topics in Microbiology and Immunology vol. 154 (1990), Springer-Verlag, New York, NY 125-169
6. Cicin-Sain L., Brune W., Bubic I., Jonjic S., and Koszinowski U.H. Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo. J. Virol. 77 15 (2003) 8249-8255
7. Fowler K.B., and Boppana S.B. Congenital cytomegalovirus (CMV) infection and hearing deficit. J. Clin. Virol. 35 2 (2006) 226-231
8. Fowler K.B., Stagno S., Pass R.F., Britt W.J., Boll T.J., and Alford C.A. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N. Engl. J. Med. 326 10 (1992) 663-667
9. Gao M., and Isom H.C. Characterization of the guinea pig cytomegalovirus genome by molecular cloning and physical mapping. J. Virol. 52 2 (1984) 436-447
10. Greaves R.F., Brown J.M., Vieira J., and Mocarski E.S. Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene. J. Gen. Virol. 76 Pt 9 (1995) 2151-2160
11. Griffith B.P., McCormick S.R., Fong C.K., Lavallee J.T., Lucia H.L., and Goff E. The placenta as a site of cytomegalovirus infection in guinea pigs. J. Virol. 55 2 (1985) 402-409
12. Hahn G., Jarosch M., Wang J.B., Berbes C., and McVoy M.A. Tn7-mediated introduction of DNA sequences into bacmid-cloned cytomegalovirus genomes for rapid recombinant virus construction. J. Virol. Methods 107 2 (2003) 185-194
13. Hartley J.W., Rowe W.P., and Huebner R.J. Serial propagation of the guinea pig salivary gland virus in tissue culture. Proc. Soc. Exp. Biol. Med. 96 2 (1957) 281-285
14. Johnson K.P. Mouse cytomegalovirus: placental infection. J. Infect. Dis. 120 4 (1969) 445-450
15. Kumar M.L., and Nankervis G.A. Experimental congenital infection with cytomegalovirus: a guinea pig model. J. Infect. Dis. 138 5 (1978) 650-654
16. Loh H.S., Mohd-Lila M.A., Abdul-Rahman S.O., and Kiew L.J. Pathogenesis and vertical transmission of a transplacental rat cytomegalovirus. Virol. J. 3 (2006) 42
17. McGregor A., and Schleiss M.R. Molecular cloning of the guinea pig cytomegalovirus (GPCMV) genome as an infectious bacterial artificial chromosome (BAC) in Escherichia coli. Mol. Genet. Metab 72 1 (2001) 15-26
18. McVoy M.A., Nixon D.E., and Adler S.P. Circularization and cleavage of guinea pig cytomegalovirus genomes. J. Virol. 71 6 (1997) 4209-4217
19. Rue C.A., Jarvis M.A., Knoche A.J., Meyers H.L., DeFilippis V.R., Hansen S.G., Wagner M., Fruh K., Anders D.G., Wong S.W., Barry P.A., and Nelson J.A. A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. J. Virol. 78 22 (2004) 12529-12536
20. Schleiss M.R. Animal models of congenital cytomegalovirus infection: an overview of progress in the characterization of guinea pig cytomegalovirus (GPCMV). J. Clin. Virol. 25 Suppl. 2 (2002) S37-S49
21. Schleiss M.R., Anderson J.L., and McGregor A. Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model. Virol. J. 3 (2006) 9
22. Schleiss M.R., Bernstein D.I., McVoy M.A., Stroup G., Bravo F., Creasy B., McGregor A., Henninger K., and Hallenberger S. The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs. Antiviral. Res. 65 1 (2005) 35-43
23. Schleiss M.R., Bourne N., Stroup G., Bravo F.J., Jensen N.J., and Bernstein D.I. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine. J. Infect. Dis. 189 8 (2004) 1374-1381
24. Schleiss M.R., and Lacayo J. The guinea pig model of congenital cytomegalovirus infection. In: Reddehase M.J. (Ed). Cytomegaloviruses: Pathogenesis, Molecular Biology and Infection Control, (2005), Horizon Scientific Press Ltd, Wymondham, Norfolk, UK
25. Schleiss M.R., Lacayo J.C., Belkaid Y., McGregor A., Stroup G., Rayner J., Alterson K., Chulay J.D., and Smith J.F. Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection. J. Infect. Dis. 195 6 (2007) 789-798
26. Schleiss M.R., Stroup G., Pogorzelski K., and McGregor A. Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine. Vaccine 24 37-39 (2006) 6175-6186
27. Smith G.A., and Enquist L.W. Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus. J. Virol. 73 8 (1999) 6405-6414
28. Woolf N.K., Jaquish D.V., and Koehrn F.J. Transplacental murine cytomegalovirus infection in the brain of SCID mice. Virol. J. 4 (2007) 26
29. Yu D., Silva M.C., and Shenk T. Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc. Natl. Acad. Sci. U.S.A. 100 21 (2003) 12396-12401
30. Yu D., Smith G.A., Enquist L.W., and Shenk T. Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J. Virol. 76 5 (2002) 2316-2328